WordNet

travel or traverse (a distance); "This car does 150 miles per hour"; "We did 6 miles on our hike every day"
the syllable naming the first (tonic) note of any major scale in solmization (同)doh, ut
proceed or get along; "How is she doing in her new job?"; "How are you making out in graduate school?"; "Hes come a long way" (同)fare, make_out, come, get along
create or design, often in a certain way; "Do my room in blue"; "I did this piece in wood to express my love for the forest" (同)make
carry on or function; "We could do with a little more help around here" (同)manage
get (something) done; "I did my job" (同)perform
of or denoted by an integer
the result of a mathematical integration; F(x) is the integral of f(x) if dF/dx = f(x)
constituting the undiminished entirety; lacking nothing essential especially not damaged; "a local motion keepeth bodies integral"- Bacon; "was able to keep the collection entire during his lifetime"; "fought to keep the union intact" (同)entire, intact
treat with an agent; add (an agent) to; "The ray dosed the paint"
the quantity of an active agent (substance or radiation) taken in or absorbed at any one time (同)dosage
a measured portion of medicine taken at any one time (同)dosage
treated with some kind of application; "a mustache dosed with bear grease"

PrepTutorEJDIC

《疑問文・否定文を作る》 / 《否定命令文を作る》 / 《助動詞とbe動詞のどちらも含まない文に用いて付加疑問を作る》 / 《強意語として》 / 《文》《助動詞とbe動詞のどちらも含まない文に用いて倒置文を作る》 / 《あいづちを打つ場合に》 / 《先行する動詞またはそれを含む述部の代用》 / 《so,nor,neitherで始まる簡略文で》 / …‘を'『する』,行う,果たす / 《通例have done,時にbe doneの形で》…‘を'『終える』,済ませる / …‘を'作る,作り出す / …‘を'『処理する』,整える,片付ける / 〈学課〉‘を'『勉強する』,専攻する / 〈利益・害など〉‘を'与える,もたらす / 〈人〉‘に'『役立つ』,用が足りる(serve) / …の速度で進む,距離を行く / …‘を'見物する / 〈劇〉‘を'上演する;…‘の'役を演じる / …の役目(仕事)をする / 《おもに英》…‘を'だます,かつぐ / 《話》…をへとへとにさせる / 『する』;活動する / 《通例have done,時にbe doneの形で》(…を)『終える』,済ます《+『with』+『名』》 / 〈事が〉『運ぶ』;〈人が〉暮らしていく,健康である / 〈物が〉(…に)『間に合う』,十分である;〈人が〉(…に)役に立つ,向く《+『for』+『名』》 / 《複数形で》すべきこと / 〈C〉《おもに英》大宴会,大パーティー / 〈C〉《英話》詐欺,ぺてん
ド(全音階の第1音)
全体の一部分として欠くことのできない,完全なものになるに必要な / 完全無欠な / (数学で)整数の
(おもに飲み薬1回分の)『服用量』 / (痛いこと・いやなことの)1回分,一定量 / (人などが受ける放射線の)線量 / 性病 / (…を)…‘に'投薬する,服用させる《+『名』+『with』+『名』》

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 高用量メトトレキサートの治療使用 therapeutic use of high dose methotrexate
2. 赤血球細胞膜の動態および機構 red blood cell membrane dynamics and organization
3. 癌治療におけるプロトンおよびイオンビーム proton and ion beams in cancer therapy
4. 侵襲的モニタリングのための動脈カテーテル留置法 arterial catheterization techniques for invasive monitoring
5. 強度変調放射線療法 intensity modulated radiation therapy

English Journal

Age-related decline in the responsiveness of motor cortex to plastic forces reverses with levodopa or cerebellar stimulation.

Kishore A1, Popa T2, James P3, Yahia-Cherif L4, Backer F3, Varughese Chacko L3, Govind P3, Pradeep S3, Meunier S5.
Neurobiology of aging.Neurobiol Aging.2014 Nov;35(11):2541-51. doi: 10.1016/j.neurobiolaging.2014.05.004. Epub 2014 May 10.
The plasticity of motor cortex is integral for motor memory and skills acquisition but it declines with aging. Forty healthy volunteers, across 6 decades, were tested to examine the (a) age-dependency of motor cortex responsiveness to plasticity induction, as measured from the response to paired ass
PMID 24908167

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study.

Isakoff SJ1, Wang D2, Campone M3, Calles A4, Leip E5, Turnbull K6, Bardy-Bouxin N7, Duvillié L8, Calvo E4.
British journal of cancer.Br J Cancer.2014 Oct 7. doi: 10.1038/bjc.2014.508. [Epub ahead of print]
Background:This phase 1 study evaluated the maximum tolerated dose (MTD), safety, and efficacy of bosutinib (competitive Src/Abl tyrosine kinase inhibitor) plus capecitabine.Methods:Patients with locally advanced/metastatic breast, pancreatic, or colorectal cancers; cholangiocarcinoma; or glioblasto
PMID 25290090

Japanese Journal

Options to Overcome Clopidogrel Response Variability

PARK Kyung Woo,KIM Hyo-Soo
Circulation journal : official journal of the Japanese Circulation Society 76(2), 287-292, 2012-01-25
… Oral antiplatelet agents targeting the platelet P2Y12 receptor are an integral component of treating patients with acute coronary syndrome and those undergoing percutaneous coronary intervention. … Namely, the data and evidence regarding increasing the dose of clopidogrel, adding cilostazol to standard dual antiplatelet therapy, and switching to more recently developed agents will be covered. …
NAID 10030035186

Experimental Model of Naturally Occurring Post-radiation Sarcoma : Interest of Positron Emission Tomography (PET) for Early Detection

PHULPIN Berengere,TRAN Nguyen,LEROUX Agnes [他],POUSSIER Sylvain,MARIE Pierre-Yves,PINEL Sophie,HUGER Sandrine,HENROT Philippe,GALLET Patrice,BLAISE Claire,BRAVETTI Pierre,GRAFF Pierre,MERLIN Jean-Louis,DOLIVET Gilles
Journal of radiation research 53(1), 101-109, 2012-01-16
… Radiotherapy is an integral part of overall cancer therapy. … Fifteen Wistars rats were irradiated unilateraly on the hindlimb with a single dose of 30 Gy. …
NAID 10030023708